Anticorps Recombinant de lapin anti-MYCN

MYCN Recombinant Antibody for WB, FC (Intra), Cytometric bead array, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, FC (Intra), Cytometric bead array, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

242406D8

N° de cat : 84886-3-PBS

Synonymes

242406D8, bHLHe37, MODED, N myc, N myc proto oncogene protein



Informations sur le produit

84886-3-PBS cible MYCN dans les applications de WB, FC (Intra), Cytometric bead array, Indirect ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène MYCN Protéine recombinante Ag27224
Nom complet v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)
Masse moléculaire calculée 50 kDa
Poids moléculaire observé~65 kDa
Numéro d’acquisition GenBankBC002712
Symbole du gène MYCN
Identification du gène (NCBI) 4613
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

MYCN, also named as BHLHE37 and NMYC, is a transcription factor. It is primarily expressed in normal developing embryos and is thought to be critical in brain and other neural development. It is often amplified in human neuroblastomas. IR34A can suppress MYCN expression, it suggest MYCN has a role in cell growth. The expression of the MCYN is upregulated in a variety of human tumors, most frequently neuroblastoma, where the level of expression appears to increase as the tumor progresses. The calculated molecuar weight of MYCN is 50 kDa, but Phosphorylated MYCN is about 65-70 kDa. MYCN exsits two isoforms and MV of isoform is respectively 65 kDa and 45 kDa. (PMID: 19615087 )

{{ptg:RelatedPrimaryAntibodies}}